Videos

Thumbnail

Paul Markham, VP, Global Marketing, Vital

Paul Markham, VP, Global Marketing with Vital said the word that made the most powerful impact at HIMSS17 was “mobile.” As interoperability continues to improve within hospitals and other ACO’s, access to timely information will be key in providing the highest quality of care to the patient.

Thumbnail

Paul Grabscheid, VP of Strategic Planning, Intersystems

At HIMSS17, attendees were focused on improving the quality of care while lowering costs. Paul Grabscheid, VP of Strategic Planning of InterSystems, explains the important role interoperability plays in finding new methods to help health systems work better with one another.

Thumbnail

Todd Rothenhaus, CMO and SVP, athenahealth

Todd Rothenhaus, MD, the CMO and SVP at athenahealth discusses at HIMSS17 the importance of independent entities working together. Care coordination and collaboration tools play a big part.

Thumbnail

Neil Simon, COO, Aprima

At HIMSS17, Neil Simon, COO of Aprima discusses the value of interoperability and the exchange of information. The right system allows providers to take better care of their patients, get properly reimbursed, and report easily to various agencies.

Thumbnail

Dave Bennett - EVP, Product & Strategy, Orion Health

Dave Bennett, EVP, Product & Strategy at Orion Health shares his thoughts on moving interoperability forward at HIMSS17. Integration must be operationalized and real-time data should be curated to move health care towards becoming a data-driven industry.

Video: Physicians sing ‘Ode to EMRs’

The times they are a changin’--most notably when it comes to health IT.

Around the web

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech. 

The sensors of certain FreeStyle Libre 3 devices are producing inaccurate glucose readings and should not be used. Two patient injuries have been reported. Abbott first reported the problem in July. 

Medications that target obesity are not typically covered by Medicare. When the FDA approved semaglutide as a way to treat certain cardiovascular risks, however, CMS said Medicare coverage was on the table. 

Trimed Popup
Trimed Popup